If you're like us, you love when an actor on your old favorite show pops up on your new favorite show. So when Christopher ...

Less than ten minutes after my CAT scan, my room in the ER was filled with a team of medical staff. Each of them had grave, ...

A single dose of an experimental drug has been found to reduce the risk of genetic heart disease by at least 94 per cent. Lepodisiran, developed by Eli Lilly, has shown promising results in reducing ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...

Wernicke-Korsakoff syndrome causes memory changes and other neurological symptoms. Learn why it’s underdiagnosed and more ...

Peripheral artery disease usually occurs in the legs and can result in severe pain, gangrene or even amputation. Up to 10% of ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Discover the key information about cardiovascular disease in Black men, including risk factors, prevention strategies, and ...

Higher Yield for Non-Daily Symptom Patients: Non-daily symptom patients—those with symptoms occurring with a frequency less than once per day—had an 80.9% arrhythmia yield versus 69.1% in ...

Coronary artery disease (CAD) continues to be a leading cause of morbidity and mortality globally. The recommendations that ...